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ABSTRACT: Domain-specific metabolic inhibitors are currently used to differentiate archaeal
from bacterial activity. However, studies testing the specificity of these inhibitors are sparse or are
based on cultured strains. We determined the inhibition specificity of erythromycin (EMY) and
N1-guanyl-1,7-diaminoheptane (GC7) on bacterial and archaeal communities in the North
Atlantic. EMY and GC7 are assumed to inhibit bacterial and archaeal activity, respectively. Het-
erotrophic prokaryotic activity was estimated via 3H-leucine incorporation on the cell-specific
level using catalyzed reporter deposition fluorescence in situ hybridization combined with
microautoradiography (MICRO-CARD-FISH). In the water masses studied, the contribution of
Thaumarchaeota to total picoplankton abundance ranged from 5 to 24% while Euryarchaeota
contributed 2 to 6%; the relative abundance of Bacteria ranged from 29 to 48%. The addition of
EMY and GC7 reduced the bulk leucine incorporation by ~77% and ~41%, respectively. Evalua-
tion of the inhibition efficiency of EMY on a cell-specific level showed no difference between
Archaea (76.0 ± 14.2% [SD]) and Bacteria (78.2 ± 9.5%). Similarly, the reduction of substrate
uptake in GC7-treated samples was similar in Archaea (59.9 ± 24%) and Bacteria (47.2 ± 9.6%).
Taken together, our results suggest that in complex open-ocean prokaryotic communities neither
EMY nor GC7 is efficient as a domain-specific inhibitor.
KEY WORDS:  N1-guanyl-1,7-diaminoheptane · Secondary production · Prokaryotes · MICRO-
CARD-FISH · Dark ocean ·Antibiotics · North Atlantic Ocean · Microautoradiography
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INTRODUCTION
Over the last 2 decades, it has become apparent that
both Archaea and Bacteria are major components of
the microbial community in the oceanic water column
(Karner et al. 2001, Herndl et al. 2005, Teira et al.
2006a). While the contribution of Bacteria to total pico -
plankton abundance decreases with depth, the rela-
tive contribution of mesophilic Archaea increases to-
ward the deep-water masses where Euryarchaeota
and Thaumarchaeota contribute up to 50% to the
total picoplankton abundance (Karner et al. 2001,
Teira et al. 2006a, Varela et al. 2008). Thaumarchaeota
play a significant role in the first step of nitrification,
utilizing ammonia (Könneke et al. 2005, Wuchter et al.
2006, Francis et al. 2007) as an energy source, and
chemoautotrophically fix carbon dioxide for biomass
synthesis (Herndl et al. 2005, Hallam et al. 2006). The
dark ocean’s chemoautotrophy is mainly attributed to
Thaumarchaeota, while Bacteria are largely consid-
ered heterotrophic, suggesting that the main meta-
bolic pathways are distinct between these 2 major
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prokaryotic groups. However, at least some Archaea
are able to take up amino acids (Ouverney & Fuhrman
2000, Teira et al. 2006b) and use organic matter as a
carbon source (Hallam et al. 2006). Indications of a
mixotrophic lifestyle within this phylum have been
found in metagenomic libraries from bathypelagic
samples (Martin-Cuadrado et al. 2008).
Catalyzed reporter deposition fluorescence in situ
hybridization, combined with micro-autoradiography
(MICRO-CARD-FISH) is a well-established method
to visualize the uptake of substrates by single cells
(Teira et al. 2004, De Corte et al. 2013). MICRO-
CARD-FISH helped in quantifying dissolved inor-
ganic carbon fixation by Thaumarchaeota in the dark
ocean (Herndl et al. 2005, Teira et al. 2006b). How-
ever, MICRO-CARD-FISH is labor- and time-con-
suming, particularly if one aims at estimating uptake
rates at the individual cell level (Sintes & Herndl
2006, Varela et al. 2011). A reliable and sensitive
method using radiolabeled substrates in combination
with group-specific antibiotics would be essential to
distinguish between archaeal and bacterial activity
in mixed communities (Levipan et al. 2007b, Yoko -
kawa et al. 2012, Berg et al. 2015a).
Metabolic inhibitors or antibiotics inhibit the growth
(bacteriostatic) or cause cell death (bactericidal) of
most microorganisms by affecting the DNA, RNA,
cell wall, or protein synthesis (Kohanski et al. 2010).
For measuring the activity of specific microbial
groups, bacteriostatic drugs are preferred over bac-
tericidal antibiotics, as the latter might lead to the
release of additional substrate via leaching of intra-
cellular material through damaged membranes,
potentially leading to stimulated growth of non-tar-
get groups. Macrolides such as erythromycin (EMY)
inhibit the elongation of the nascent peptide chain
that leaves the ribosomal exit tunnel of the 50S sub-
unit (Wilson 2014). From studies on clinically impor-
tant prokaryotes, it is assumed that EMY reversibly
inhibits Bacteria, leaving Archaea and eukaryotes
unaffected (Tu et al. 2005, Dunkle et al. 2010).
Despite their widespread occurrence in the guts of
animals including humans, archaeal pathogens have
not been identified thus far (Cavicchioli et al. 2003,
Eckburg et al. 2003). Yet, some antibiotics such as
diphtheria toxin have been found to inhibit eukary-
otes and Archaea (Kessel & Klink 1980). In a recent
study, diphtheria toxin caused specific inhibition of
Archaea in a natural microbial community of the
North Atlantic (Yokokawa et al. 2012). However,
diphtheria toxin is rather expensive and conse-
quently is not suited for routine application in large
sampling programs.
In a laboratory study, the cell cycle of several
archaeal extremophiles was arrested by the addition
of the spermidine analog N1-guanyl-1,7-diamino-
heptane (GC7) (Jansson et al. 2000). In eukaryotes,
GC7 irreversibly binds near the active center of the
enzyme deoxyhypusine synthase (DHS) (Umland et
al. 2004) and reversably also in Archaea (Jansson et
al. 2000), thereby inhibiting the hypusination of the
initiation factor eIF-5A (Murphey & Gerner 1987,
Park et al. 2006). The initiation factor eIF-5A and its
homolog aIF-5A (Bartig et al. 1992, Eichler & Adams
2005) are vital proteins for cell proliferation in
eukaryotes and Archaea, respectively (Park et al.
2010). Kyrpides & Woese (1998) reported a universal
conservation of these translation initiation factors
(EF-P in Bacteria). Nevertheless, it has been sug-
gested that hypusine, a post-translationally modified
amino acid, is absent in Bacteria (Gordon et al. 1987,
Jansson et al. 2000). However, recent studies found
functional DHS homologs in extensive BLAST
searches that might indicate a probable role of hypu-
sine in several bacterial species (Brochier et al. 2004,
López-García et al. 2004). The exact functions and
mechanisms by which the IF-5A reacts in the eukary-
otic cell and which function it has, however, are still
under debate (Zanelli & Valentini 2007). Neverthe-
less, GC7 has recently been proposed as an inexpen-
sive and efficient inhibitor for Archaea (Levipan et al.
2007a,b, Farias et al. 2009). However, knowledge on
the specificity of GC7 in Archaea is based on a few
culture experiments with simple community compo-
sition (Jansson et al. 2000, Löscher et al. 2012, Berg et
al. 2015b). Consequently, the specificity of GC7 has
not been extensively tested on complex natural
microbial assemblages.
Therefore, the objective of this study was to test
the specificity of the 2 widely used inhibitors EMY
and GC7 on natural, complex prokaryotic assem-
blages throughout the water column of the North
Atlantic and to determine the relative contribution
of Bacteria and Archaea to the bulk heterotrophic
microbial activity. We measured bulk heterotrophic
activity via 3H-leucine incorporation and used
MICRO-CARD-FISH combined with automated cell
counting to evaluate the cell-specific activity of Bac-
teria and Archaea in the presence and absence of
these metabolic inhibitors. While the bulk measure-
ments suggested selective inhibition of microorgan-
isms, cell-specific analyses revealed that neither
EMY nor GC7 are sufficiently specific to allow a
clear differentiation of archaeal from bacterial activ-
ity by using these 2 inhibitors on complex prokary-
otic communities.
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MATERIALS AND METHODS
Sample collection
During a North Atlantic Cruise (MEDEA-2) with the
RV ‘Pelagia’ between 21 June and 22 July 2012, sea-
water samples of 25 l each were taken at 7 stations be-
tween 49 and 64° N and between 6 and 40° W using 19
Niskin bottles (Ocean Test Equipment) mounted on a
rosette frame equipped with a conductivity, tempera-
ture, depth (CTD, SBE911plus, Sea-Bird Electronics),
and oxygen sensor (SBE 43, Sea-Bird Electronics). Be-
fore each operation, the sensors were re-calibrated for
drift (WOCE operations manual 1994). Deep-water
masses were identified by salinity−temperature plots.
The samples for the inhibition experiments were col-
lected from the subsurface layer (SSL, ~100 m), the
relative oxygen minimum layer (O2-min, ~500 m), the
upper Labrador Sea Water (uLSW, ~1000 m), and the
Norwegian Sea Deep Water (NSDW, ~3000 m). The
physico-chemical properties of the water masses are
presented in Table 1.
Picoplankton abundance
Picoplankton abundance was determined by flow
cytometry (Marie et al. 1997). Briefly, duplicate sea-
water samples were fixed with electron microscopy-
grade glutaraldehyde (0.5% final concentration),
flash-frozen in liquid nitrogen, and stored at −80°C
until analysis. In the home laboratory, the samples
were thawed and stained with SYBR Green I (Life
Technologies) in the dark for 10 min. Cytograms of
side scatter versus fluorescence (excitation at 488 nm,
emission at 530 nm) were used to identify picoplank-
ton cells on an Accuri C6 flow cytometer (BD Bio-
sciences). Counts were calibrated with known con-
centrations of fluorescent 1 µm plastic spheres
(Molecular Probes).
Treatments with antibiotics
Based on the results of the pre-exposure and con-
centration tests, 60 min prior to adding 3H-leucine
the antibiotics were added to parallel sets of sea -
water samples. For inhibition of Bacteria, seawater
samples were incubated according to T. Yokokawa
(pers. comm.) with EMY (Sigma-Aldrich, stock solu-
tion: 13.6 mmol L−1 in ethanol), at a final concentra-
tion of 68 µmol L−1. For the inhibition of Archaea, sea-
water samples were incubated following Jansson et
al. (2000) with GC7 (Biosearch Technologies, stock
solution: 50 mmol L−1 in acetic acid) at a final concen-
tration of 1.0 mmol L−1. Volumes of the incubations
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WM Lat. Long. Depth Temp. Salinity σθ NH4 NO3 PO4 Si O2
Stn (°N) (°E) (m) (°C) (kg m−3) (µmol kg−1) (µmol kg−1) (µmol kg−1) (µmol kg−1) (µmol kg−1)
SSL
8 51.34 326.87 98 11.0  35.23 26.95 0.14 9.54 0.63 4.08 253
12 53.38 319.93 99 5.5 34.79 27.45 0.15 18.76 1.18 10.02  243
18 57.62 332.19 99 8.3 35.03 27.25 0.14 13.59 0.88 5.44 262
20 61.32 341.89 99 8.9 35.20 27.28 0.13 12.62 0.82 4.39 263
22 64.07 354.1  99 3.4 34.93 27.80 0.47 10.39 0.74 4.15 302
O2-min
8 51.34 326.87 392 6.7 34.88 27.37 0.11 18.90 1.24 10.73  218
12 53.38 319.93 495 4.0 34.88 27.69 0.13 16.59 1.09 8.45 290
20 61.32 341.89 726 7.0 35.15 27.54 0.11 18.27 1.18 10.07  225
22 64.07 354.1  248 1.9 34.97 27.96 0.08 13.73 0.92 5.47 291
uLSW
8 51.34 326.87 1086  4.0 34.92 27.73 0.08 17.28 1.12 10.05  274
12 53.38 319.93 989 3.7 34.89 27.73 0.13 17.09 1.11 9.68 281
20 61.32 341.89 988 5.1 35.01 27.68 0.10 18.44 1.20 10.90  247
NSDW
22 64.07 354.1  3137  –0.8  34.91 28.08 0.05 15.69 1.04 14.07  282
Samples taken to determine pre-exposure time and concentration of inhibitors
TRNS
1 49.23 347.98 823 9.9 35.63 27.47 ND ND ND ND 191
O2-min
5 51.3  336.55 689 8.9 35.28 27.36 ND ND ND ND 194
Table 1. Geographic location and physico-chemical characteristics of the sampled water masses (WM). SSL: subsurface layer
(~100 m); O2-min: oxygen-minimum of the water column at that station; uLSW: upper Labrador Sea Water; NSDW: Norwegian 
Sea Deep Water; TRNS: transitional; ND: not determined
Aquat Microb Ecol 77: 99–110, 2016
were chosen depending on depth and the measured
parameter (see next section). After the pre-exposure
time at in situ temperature in the dark, the samples
were processed as described below for the bulk
leucine incorporation or MICRO-CARD-FISH.
Bulk leucine incorporation and 
MICRO-CARD-FISH
Bulk leucine incorporation by heterotrophic pico -
plankton was determined following Reinthaler et al.
(2010). Briefly, for each treatment and control, tripli-
cate water samples of 10 to 40 mL (depending on
sampling depth) and 2 formaldehyde-treated blanks
(2% final concentration) were spiked with 3H-leucine
(specific activity 120 Ci mmol−1, PerkinElmer) to final
concentrations of 5 nmol L−1 in the O2-min, uLSW,
and NSDW samples, and 10 nmol L−1 in the SSL sam-
ples. Following incubation at in situ temperature in
the dark for 4 h (SSL), 12 h (O2-min and uLSW), or
24 h (NSDW), the samples were filtered through
0.2 µm polycarbonate filters (Nuclepore, Whatman)
supported by 0.45 µm cellulose nitrate  filters (HAWP,
Millipore) and rinsed twice with 5 mL of an ice-cold
aqueous solution of 5% trichloroacetic acid (ACS-
grade, Sigma-Aldrich), transferred to 20 mL scintilla-
tion vials and allowed to dry at room temperature.
Scintillation cocktail (8 mL; FilterCount, Canberra-
Packard) was added, and after 18 h the filters were
counted on a Tricarb 3100TR scintillation counter
(Perkin Elmer). The disintegrations per min ute (dpm)
were corrected for quenching with internal and ex-
ternal standards. The leucine incorporation rate was
calculated using the dpm of live samples corrected for
the readings of the formaldehyde-treated blanks.
In parallel with the bulk leucine incorporation
measurement, MICRO-CARD-FISH was performed
according to Teira et al. (2004). Briefly, 3H-leucine
was added to the inhibitor-treated and control seawa-
ter samples (20−80 mL) with concentrations equal to
the bulk measurements. Incubation time and temper-
ature were chosen accordingly. At the end of the incu-
bations, formaldehyde was added at a final concen-
tration of 2%. Following fixation for 18 h at 4°C, the
samples were filtered through 0.2 µm pore size poly-
carbonate filters (GTTP, Millipore) and rinsed twice
with Milli-Q water. The filters were allowed to dry at
room temperature for several minutes and stored in
microfuge vials at −80°C until further processing.
Back in the lab, the filters were thawed and
embedded in 0.1% low-gelling-point agarose and
subsequently dried at 37°C for 10 min. Cell wall per-
meabilization was achieved with lysozyme (10 mg
mL−1, 37°C, 1 h) for Bacteria and HCl (0.1 mol L−1,
20°C, 1 min) for Archaea. Hybridization was per-
formed with horseradish peroxidase-labeled probes
specific for Bacteria, SAR11, Thaumarchaeota, and
Euryarchaeota, additionally with Non-EUB338 (for
probe sequences and hybridization conditions see
Table S1 in the Supplement at www.int-res.com/
articles/suppl/a077p099_supp.pdf) provided at a ra -
tio of 1:20 of probe to hybridization buffer at 35°C for
16 h in the dark in rotating vials (5 rpm min−1). Signal
amplification was performed by incubating filter sec-
tions in a substrate mix of 1:100 dilution of tyramides
linked to the fluorescent dye Atto488 in an amplifica-
tion buffer in the presence of H2O2 (final concentra-
tion 0.0015%) at 37°C for 40 min.
In a darkroom, the hybridized filter sections were
transferred onto pre-cleaned microscopic glass slides
coated with photographic emulsion (Ilford K.5; Ilford
Photo) to a thickness of ~10 µm. The slides were incu-
bated at 4°C in a light-tight box containing silica
beads for 6 to 8 d. The exposure time for autoradiog-
raphy was optimized, based on tests, where sections
of each filter were screened for silver granules with-
out prior hybridization. To prevent systematic varia-
tion between treatments and control due to handling,
emulsion thickness, or emulsion age, corresponding
filter sections were incubated on the same slide.
After exposure, the slides were developed and fixed
according to the manufacturer’s specification (Ilford
Photo). The filter sections were peeled off as de -
scribed by Samo et al. (2014) using a cold spray (Cold
75 Super; CRC Industries Europe BVBA). The cells
on the microscopic slides were counterstained and
mounted in a mix of Vectashield (Vector Laborato-
ries), phosphate-buffered saline, and Citifluor in a
dilution ratio of 1:2:12, containing 1 µg mL−1 4’,6-
diamino-2-phenylindole (DAPI).
Microscopic image acquisition and evaluation
Microscopy was performed on an epifluorescence
microscope (Axio Imager M2, Carl Zeiss), equipped
with an oil-immersion objective lens (Plan-Apochro-
mat 100×/1.46, Carl Zeiss) and a black-and-white
high-resolution camera (AxioCam MRm, Carl Zeiss).
For each filter section, at least 10 pictures with a total
of more than 300 DAPI-stained cells were taken using
the filter sets for Atto488 and DAPI in the epifluores-
cence as well as the transmission mode. A set of 3 pic-
tures was overlaid and the composite pictures were
evaluated using custom-made software (DotAre, A.
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H. Frank et al. unpubl. data). The size of silver-grain
halos around cells, indicative of the uptake of radio -
labeled tracer, was measured. The software para -
meters for detection of cells and silver-grain halos
were optimized with a training set of 10 manually
counted pictures using the whole range of possible
configurations. The software-annotated pictures were
manually controlled. Microbial cells were classified
as probe-positive if a DAPI-stained cell showed a
fluo rescence signal of the specific hybridization
probe. Probe-negative cells were those visibly stained
with DAPI only. All fluorescent cells were checked for
overlap with a silver-grain halo. Distinct Atto488 fluo-
rescence, but without DAPI signal, were also classi-
fied as leucine-positive cells. The percentage of cells
with silver-grain halo but no DAPI fluorescence was
2.4 ± 2.3%. Hybridization with Non-EUB338 probe,
to determine the percentage of unspecific binding,
yielded 1.4 ± 0.4% (n = 13) probe-positive cells.
Cell-specific and group-specific leucine uptake
Bulk leucine incorporation was normalized to the
respective total cell-bound silver-grain area. Subse-
quently, the obtained ratio with units of nmol Leu d−1
µm−2 was multiplied with the silver-grain area associ-
ated with leucine-positive cells and normalized to the
cell abundance of the filter area. This resulted in an
average probe-positive cell-specific leucine uptake
rate per day in units of amol cell−1 d−1.
The bulk leucine incorporation was divided by the
total cell-bound silver-grain halo area and multiplied
with the silver-grain halo area of the specific probe-
positive cells to determine the cell-specific leucine
incorporation per prokaryotic group (in units of nmol
m−3 d−1).
Calculation of inhibition efficiency, specificity, 
and statistics
To account for the filter-associated variability of
total probe-positive cells, we normalized the activity
based on the encountered probes in each treatment
via the probe-specific activity (PSA):
PSA = Pa/Pt (1)
where Pa is either the count of active probe-positive
cells or the silver-grain halo area and Pt is the total
number of probe-positive cells.
The inhibition efficiency (IE) was determined as
the ratio of the group-specific leucine uptake of the
inhibitor-treated sample (PSAtreat) and its respective
control (PSActr):
IE = [1 − (PSAtreat/PSActrl)] × 100% (2)
To calculate the inhibition specificity (IS) of each
inhibitor, the determined IE based on cell abundance
and silver-grain halo area was used:
IS = (IETG − IENTG)/IENTG (3)
Depending on the inhibitor used, the target group
(TG) and the non-target group (NTG) of the inhibitor
are either the archaeal or bacterial taxa.
Possible treatment-related or a non-random cell-
loss effect during the peeling of the filter after micro -
autoradiography was determined for each treatment
by comparing the ratio of bacterial to thaumarchaeo-
tal cell abundance using 1-way analysis of variance
(ANOVA). All statistical prerequisites for ANOVA
were tested and met. No statistical difference was
found between the treatments. All statistical analyses
were conducted with SigmaPlot Version 12. Values
are given as mean ± SD if not stated otherwise.
RESULTS AND DISCUSSION
Characterization of the pelagic prokaryotic 
community and its environment
Water samples were collected in the North Atlantic
at 7 stations between 49 and 64° N and from 100 to
3100 m depth (Fig. S1 in the Supplement at www.
int-res.com/ articles/ suppl/ a077 p099 _supp.pdf). The
physico-chemical characteristics of the depth hori-
zons sampled were similar to recent surveys in the
North Atlantic (Table 1) (Reinthaler et al. 2013). The
prokaryotic abundance ranged from 4.1 × 105 cells
mL−1 in the epipelagic SSL (100 m depth) to 0.6 × 105
cells mL−1 in the bathypelagic NSDW.
The relative abundance of Bacteria determined
by CARD-FISH was 41 ± 6% in the lower epi- and
upper mesopelagic zone, and 37 ± 7% in the uLSW
(Table 2). Similarly, in the NSDW, 37% (n = 1 water
sample) of the picoplankton were identified as Bac-
teria.  Generally, the relative percentage of Bacteria
was in agreement with an earlier study of the
northern North Atlantic deep waters (Teira et al.
2006a). The SAR11 clade dominated the bacterial
community, contributing 21 ± 9% to the total pico -
plankton abundance (Table 2). A similar contribution
of SAR11 to total picoplankton abundance was
recently reported for the North Atlantic (Lekunberri
et al. 2013).
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The relative abundance of Thaumarchaeota was
also in the range of earlier reports from this region of
the North Atlantic (Teira et al. 2006a, Yokokawa et
al. 2012, Lekunberri et al. 2013) and highest in the
O2-minimum layer with 21 ± 3% of total picoplank-
ton abundance and lowest in the SSL with 9 ± 3%.
Over the whole water column, thaumarchaeotal rela-
tive abundance ranged from ~5 to 24% (Table 2).
The contribution of Euryarchaeota to the total pico -
plankton abundance was low and rather constant
from the epi- to the bathypelagic zone of the North
Atlantic, averaging 3 ± 2% (Table 2).
The total coverage of the picoplankton community
with CARD-FISH using our complementary set of
probes (see Table S1 in the Supplement for probes
used in this study) ranged from 44 to 73% of all
DAPI-positive cells, which is similar to the recovery
efficiency reported in earlier studies (Karner et al.
2001, Church et al. 2003, Teira et al. 2004). The com-
munity composition determined by CARD-FISH did
not correlate with salinity, temperature, or inorganic
nutrients in the different water masses (Table 2).
Bulk leucine incorporation rates decreased from 52 ±
33 nmol m−3 d−1 in the SSL to 1.9 ± 0.5 nmol m−3 d−1 in
the uLSW and 1.4 nmol m−3 d−1 in the NSDW
(Table 2). Bulk leucine uptake was correlated with
depth and prokaryotic abundance (Tables S2 & S3 in
the Supplement).
Cell-specific leucine incorporation rate (i.e. bulk
leucine incorporation/abundance of leucine-positive
cells determined by MICRO-CARD-FISH) decreased
with depth and ranged from 2.1 to 0.01 amol Leu
cell−1 d−1 (Table 3). The percentage of cells taking up
leucine did not significantly change between the
 water masses (Table 3). Thus, the number of leucine-
positive cells decreased with the general depth-
 related trend (Table 2). Assuming a theoretical con -
version factor of 1.55 kg C mol−1 leucine with no
isotope dilution (Simon & Azam 1989) and an average
carbon content of 10 fg C cell−1 (Ducklow et al. 2000)
resulted in doubling times of 4 ± 3 d in the SSL, 18 ±
10 d in the O2-min, 54 ± 16 d in the uLSW, and 47 d in
the NSDW. These turnover times are in agreement
with other studies of the meso- and bathypelagic
realm of the North Atlantic (Reinthaler et al. 2006).
Pre-exposure time and concentration of 
EMY and GC7
To determine the optimal IE in terms of inhibitor
concentration and the duration of the pre-exposure
time to the inhibitor, experiments were conducted at
2 stations (Stns 1 and 5, Fig. S1 in the Supplement
and Table 1).
For the EMY-treated samples, leucine incorporation
was similar in samples with a pre-exposure time of 30
and 60 min (4.8% lower than at 30 min). A concentra-
tion of 27 µmol L−1 of EMY decreased bulk leucine in-
corporation to a similar level as the addition of 68 µmol
L−1 (Fig. 1, Holm-Sidak: t = 3.5, p = 0.177). Based on
these results, for all further experiments we used
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WM PA-F Leu incorp Bacteria SAR11 Thaumarchaeota Euryarchaeota
Stn (cells mL−1 × 104) (nmol m−3 d−1) (%) % (%) (%)
SSL
8 40.78 96.15 48 13 8 5
12 22.37 21.79 39 22 12 2
18 30.05 39.32 40 16 12 2
20 30.18 25.30 36 12 6 2
22 39.58 75.58 38 30 5 6
O2-min
8 17.48 12.65 43 36 18 6
12 15.09 6.31 44 20 20 3
20 13.06 4.81 30 16 24 2
22 25.50 18.22 49 30 21 3
uLSW
8 7.59 2.27 40 16 10 2
12 7.80 1.32 43 15 11 3
20 8.92 2.20 29 13 14 4
NSDW
22 5.92 1.35 37 36 10 5
Table 2. Microbial abundance, leucine uptake, and major prokaryotic groups assessed by CARD-FISH in the northern North
Atlantic. Abbreviations for water masses (WM) as in Table 1; PA-F: prokaryotic abundance measured by flow cytometry, Leu 
incorp: 3H leucine incorporation
68 µmol L−1 of EMY (final concentration) and a pre-
 exposure time of 60 min. This approach resulted in an
inhibition of leucine incorporation of 75 ± 6% (n = 8),
similar to that reported by Yokokawa et al. (2012).
In the GC7-treated samples, a final GC7 concentra-
tion of 1 mmol L−1 reduced the incorporation of
leucine to ~62% of the leucine incorporation of the
untreated control (Fig. 1). A GC7 concentration of
0.1 mmol L−1 resulted in an 18% higher leucine incor-
poration than the 1 mmol L−1 treatments (Holm-
Sidak: t = 40.4, p = 0.016). Inhibition of leucine incor-
poration by GC7 was similar in the 30 min and the
60 min pre-exposure time (Holm-Sidak: t = 1.99, p =
0.296; Fig. 1). In all subsequent experiments, a
1 mmol L−1 final GC7 concentration and a pre-expo-
sure time of 60 min were used.
The combined addition of the supposedly comple-
mentary inhibitors did not result in a complete inhibi-
tion of leucine incorporation (Fig. 1). Generally, most
microorganisms are susceptible to antibiotics (Wilson
2014), although multidrug resistance is assumed to
be widespread (Dunkle et al. 2010, Kohanski et al.
2010). More specifically, for a variety of pathogenic
Bacteria, single and multidrug resistance has been
reported (Levy & Marshall 2004). Furthermore, sev-
eral isolated soil Bacteria seem to be able to meta -
bolize antibiotics as their sole carbon source (Dantas
et al. 2008, but see also Walsh et al. 2013). According
to Jansson et al. (2000), GC7 causes a reversible inhi-
bition of archaeal cell growth. Thus, the polyamine
could also stimulate the growth of resistant microor-
ganisms. However, the effects of a drug combination
on bacterial survival are manifold, ranging from
additive to synergistic or antagonistic (Kohanski et
al. 2010). Thus, we cannot exclude a suppression
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WM Leu-pos. cells Bacteria SAR11 Thaumarchaeota Euryarchaeota
Treatment (%) (amol Leu cell−1 d−1) (amol Leu cell−1 d−1) (amol Leu cell−1 d−1) (amol Leu cell−1 d−1)
SSL (n = 5)
CTRL 47 ± 9 2.1 ± 1.1 1.7 ± 1.0 0.57 ± 0.49 0.82 ± 0.71
EMY 28 ± 18 0.84 ± 0.8 0.34 ± 0.22 0.12 ± 0.15 0.09 ± 0.08
GC7 32 ± 11 1.8 ± 1.2 0.85 ± 0.71 0.40 ± 0.35 1.16 ± 0.88
O2-min (n = 4)
CTRL 50 ± 3 0.39 ± 0.28 0.38 ± 0.24 0.12 ± 0.06 0.32 ± 0.18
EMY 22 ± 6 0.15 ± 0.08 0.12 ± 0.06 0.047 ± 0.038 0.13 ± 0.08
GC7 40 ± 5 0.24 ± 0.18 0.15 ± 0.16 0.052 ± 0.023 0.24 ± 0.14
uLSW (n = 3)
CTRL 42 ± 13 0.13 ± 0.07 0.098 ± 0.039 0.013 ± 0.007 0.065 ± 0.051
EMY 36 ± 2 0.042 ± 0.023 0.025 ± 0.011 0.013 ± 0.007 0.036 ± 0.011
GC7 48 ± 22 0.096 ± 0.09 0.085 ± 0.033 0.10 ± 0.12 0.11 ± 0.09
NSDW (n = 1)
CTRL 38 0.18 0.16 0.014 0.13
EMY 22 0.12 0.081 0.010 0.027
GC7 39 0.13 0.13 0.030 0.054
Table 3. Percentage of leucine-positive (Leu-pos.) picoplankton cells and cell-specific leucine uptake of specific microbial
groups in the erythromycin (EMY) and N1-guanyl-1,7-diaminoheptane (GC7) treated samples and the untreated control
(CTRL). WM: water masses (abbreviations as in Table 1). The percentage of Leu-pos. cells of DAPI-stained cells was
 calculated as mean ± SD. Leucine uptake rates were calculated from bulk leucine incorporation (via scintillation counts) and 
silver-grain area attributed to group-specific probes
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interaction (Chait et al. 2007, Kohanski et al. 2010)
between EMY and GC7. This might, at least partly,
explain the incomplete inhibition of leucine incorpo-
ration in the combined EMY+GC7 treatment result-
ing in a leucine incorporation amounting to ~19% of
the untreated control (Fig. 1).
Qualitative and quantitative assessment 
of IE and IS
In the untreated control, approximately half of the
DAPI-stained cells (46 ± 8%) were taking up leucine
throughout the water column. The EMY treatment
generally resulted in a higher inhibition (41 ± 13%)
of leucine uptake than GC7 (17 ± 14%) based on the
number of leucine-positive cells in the untreated
 controls (Table 3, Fig. S2 in the Supplement).
To investigate potential group-specific inhibition of
leucine uptake induced by EMY and GC7, MICRO-
CARD-FISH was used. The group-specific uptake
was determined for the SAR11 clade, Bacteria, Thau-
marchaeota, and Euryarchaeota, in both the inhibitor
treatments and the respective controls (Fig. 2). In the
untreated controls of the SSL, SAR11 contributed
most to the picoplankton leucine uptake, while
Thaumarchaeota and Euryarchaeota contributed
only a minor fraction (Fig. 2A). The relative contribu-
tion of SAR11 to total leucine uptake decreased with
depth, while the contribution of Thaumarchaeota
and Euryarchaeota increased (Fig. 2D).
In EMY- and CG7-treated samples, bulk leucine
uptake was reduced to 25 and 59%, respectively, of
the untreated controls (Fig. 2B,C). The percentage of
leucine-positive cells in the EMY and GC7 treat-
ments remained fairly constant over the entire depth
range (Table 3). In contrast, the per-cell activity of all
specific groups examined (Bacteria, SAR11, Thau-
marchaeota, Euryarchaeota) decreased with depth
by 1 order of magnitude in the untreated controls
(Table 3). The contribution of Euryarchaeota was
~3% and thus near the detection limit of the CARD-
FISH method, which we evaluated using a non-sense
probe for hybridization (Table S1 in the Supplement).
We therefore did not include Euryarchaeota in the
assessment of the IE. Nevertheless, on the cell-
 specific level, the effect of the inhibitors was thor-
oughly investigated for  Euryarchaeota.
106
0 20 40 60 80 100
NSDW
uLSW
O2-min
SSL
Leu incorp. (nmol m–3 d–1)
0 20 40 60 80 100
NSDW
uLSW
O2-min
SSL
Bacteria 
Thaumarchaeota
Euryarchaeota
SAR11-clade
EMY
Percent of control (%)
0 20 40 60 80 100
GC7
Percent of control (%)
0 20 40 60 80 100
Percent of total bulk leucine uptake (%)
0 20 40 60 80 100 0 20 40 60 80 100
A B C
D E F
CONTROL
Fig. 2. Response of bulk and taxa-specific leucine uptake to inhibitors in different water masses. (A) Distribution of total bulk
leucine uptake among several microbial taxa based on quantifying the silver-grain area attributed to the different taxonomic
groups identified via MICRO-CARD-FISH. Leucine uptake of the different microbial taxa in percent of the untreated control
following the addition of (B) EMY and (C) GC7 to samples of different water masses: subsurface layer (SSL), oxygen minimum
(O2-min), upper Labrador Sea Water (uLSW), and Norwegian Sea Deep Water (NSDW). Error bars in (A) represent the 
standard deviation of bulk leucine incorporation
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Effect of EMY
In EMY-treated samples, the distribution
pattern of leucine uptake into the different
taxa was similar to that in the untreated con-
trols (Fig. 2D,E, Table S4 in the Supplement).
The addition of EMY affected cell-specific
activity of Bacteria and Thaumarchaeota sim-
ilarly. Cell-specific bacterial activity, calcu-
lated on pairwise  comparisons of EMY-
treated incubations with the respective
controls, decreased by 59 ± 21% (Table 3).
Thaumarchaeotal activity decreased by 52 ±
38% as compared to the untreated controls.
Euryarchaeotal activity decreased by 63 ±
25%, and cell-specific activity associated with
the SAR-11 cluster decreased by 69 ± 18% in
the EMY treatments (Table 3). No significant
difference between the different taxa was
found in the percentage of inhibition in the
EMY treatments as compared to the controls
(Kruskal-Wallis 1-way ANOVA on ranks, H =
2.0, df = 3, p = 0.572). To assess the IE of EMY
and GC7 for each taxonomic group, we calcu-
lated the reduction in the relative fraction of
the leucine-positive cells for each inhibitor
treatment compared to its control (Eqs. 2 & 3).
In addition to counting silver-grain-associ-
ated cells, the silver-grain halo area around
each leucine-positive cell was calculated to
obtain leucine uptake per cell (see ‘Materials
and methods’ for details).
The IE of EMY, based on the abundance of
leucine-positive cells, was variable, albeit
similar for Bacteria (38 ± 25%) and Thaum -
archaeota (31 ± 39%) (t20 = 0.50, p = 0.31;
Table 4). Likewise, the IE of leucine-positive
cells calculated from the silver-grain halo
area was not significantly different between
Bacteria (78 ± 9%) and Thaumarchaeota (76 ±
14%) (t20 = 0.43, p = 0.33; Table 4). The IE con-
sidering the halo area is higher compared to
the abundance-based IE. This indicates that
leucine uptake of a considerable part of the
community was not completely inhibited by
EMY, but reduced to about 25% of its original
value. Thus, the IS index, which is the relative
difference in IE between the target and the
non-target group normalized to the IE of
the non-target group, was only 0.18 ± 0.68
(Table 4). This suggests that EMY caused a
bacterial inhibition that was only 18% higher
compared to the inhibition of the Thaumar-
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chaeota and not significantly different from 0 consid-
ering the large standard deviation. Clearly, EMY also
severely affected Thaumarchaeota in our samples.
While EMY is assumed to be a specific inhibitor for
Bacteria (Dunkle et al. 2010, Wilson 2014), reports
suggest that horizontal gene transfer and/or muta-
tions of ribosomal binding sites might alter the sus-
ceptibility to EMY in archaeal and bacterial species
(Weisblum 1995, Tu et al. 2005, Dunkle et al. 2010).
In the only study investigating the efficiency of EMY
on a cell-specific level in natural complex communi-
ties, Yokokawa et al. (2012) suggested specific inhi-
bition and an IE of ~90% on Bacteria. It is important
to note, however, that all other studies concerning
the efficiency of EMY are related to medically rele-
vant organisms (e.g. Staphylococcus aureus) and do
not consider natural prokaryotic assemblages.
Effect of GC7
The general tendency of the bulk leucine uptake
between the investigated taxonomic groups in the
GC7 treatments was very similar to the pattern ob -
served in the controls (compare Fig. 2D,F and
Table S4 in the Supplement). The average reduction
in cell-specific leucine uptake, measured as the pair-
wise difference to the respective control, was gener-
ally low and variable, amounting to 17 ± 57% for
Thaumarchaeota as compared to 21 ± 28% for Bacte-
ria (Table 3). SAR11-associated cell-specific leucine
up take decreased by 36 ± 51%, while euryarchaeotal
activity changed by −7 ± 71%. No significant differ-
ence between the different taxa was found in the per-
centage of inhibition in the GC7 treatments as com-
pared to the controls (Kruskal-Wallis 1-way ANOVA
on ranks; H = 3.29, df = 3, p = 0.349). In some samples,
the GC7 treatment led to a higher cell-specific
leucine uptake than in the untreated control (e.g.
Thaumarchaeota in the NSDW). This stimulating ef-
fect was also reported earlier for GC7 (Yoko kawa et
al. 2012) and recently for diphteria toxin in archaeal
enrichments from the Baltic Sea (Berg et al. 2015b).
The relatively high inhibition of Bacteria in GC7
treatments implied that GC7 is not as specific as pre-
viously assumed (Löscher et al. 2012). The IE based
on the number of leucine-positive cells was not sig-
nificantly different between Thaumarchaeota (48 ±
73%) and Bacteria (29 ± 35%), even after removing
samples in which a stimulation of leucine uptake was
found (Table 4, Mann-Whitney U-test: U = 20, p =
0.083). Similarly, using the silver-grain halo area to
calculate the IE resulted in an insignificantly higher
inhibition of Thaumarchaeota (median = 66%, range
= 69%) than of Bacteria (median = 49%, range =
32%) (Table 4, Mann-Whitney U-test: U = 27.5, p =
0.123). The average IS of GC7 was 0.89 ± 1.72, indi-
cating an 89% higher inhibition of Thaumarchaeota
than of Bacteria (Table 4). However, the large stan-
dard deviation of IS (172%) suggests a rather low
specificity of the inhibitor GC7. Thus, our data
strongly suggest that Bacteria are susceptible to
GC7. Remarkably, Jansson et al. (2000) already re -
ported an increased turnover time of Escherichia coli
by ~ 30% when grown in a solution containing 1 mM
GC7. They concluded that an elevated poly amine
level, modulating the functions of RNA, DNA, nu-
cleotide triphosphates, proteins, and other acidic
substances within bacterial cells (Igarashi & Kashi-
wagi 2000), might be responsible for unspecific ef -
fects, causing the delay in cell growth. Moreover, it
was shown that the elongation factor eF-5A, associ-
ated with cell proliferation, is rather stable in mam-
malian cells (Nishimura et al. 2005). This would
argue for long pre-exposure periods of several days
until GC7 shows an inhibitory effect. Recently, Olive-
rio et al. (2014) found that GC7 can affect cell-consti-
tuting processes by mechanisms other than inhibition
of the DHS, which transfers the aminobutyryl moiety
of the polyamine spermidine to the ε-amine of a con-
served lysine in the precursor of the elongation factor
to form deoxyhypusine. Thus, the mechanism by
which Bacteria are affected by GC7 is not necessarily
due to a reaction with DHS, which was the basis for
the selection of this inhibitor as being specific. Based
on a few archaeal isolates, specific inhibition of ar-
chaeal activity by GC7 was reported (Löscher et al.
2012, Berg et al. 2015b). Thus far, the assessment of
IS on the bases of cell-specific evaluation has only
been conducted under artificial (culture) conditions
and tested with selected model organisms (e.g. Jans-
son et al. 2000, Kannan & Mankin 2011, Löscher et al.
2012). Initially, GC7 was proposed simply as a
cheaper alternative to diphtheria toxin to inhibit ar-
chaeal activity. According to recent studies, however,
the specificity of diphtheria toxin might have adverse
and non-inhibitory effects as well (Berg et al. 2015a).
CONCLUSIONS
Taken together, our data suggest that the addition
of EMY to open-ocean microbial communities in -
hibits leucine incorporation of Bacteria and Archaea
to a similar degree. Moreover, GC7, meant to be an
Archaea-specific inhibitor, reduces leucine uptake of
108
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Archaea and Bacteria to an unspecific, but variable
extent. This indicates that the inhibitors EMY and
GC7 are not as specific as commonly assumed. Fur-
thermore, our findings indicate that inhibitory sub-
stances need to be carefully tested on a single-cell
level in the relevant natural environment before
being applied to a bulk community level to differen-
tiate activity rates among different microbial groups.
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